ALXN : Summary for Alexion Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets closed

Alexion Pharmaceuticals, Inc. (ALXN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
116.82-1.90 (-1.60%)
At close: 4:00PM EDT
People also watch
REGNBMRNVRTXBIIBCELG
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close118.72
Open118.64
Bid116.73 x 100
Ask117.90 x 100
Day's Range115.57 - 119.29
52 Week Range109.12 - 159.93
Volume1,751,416
Avg. Volume1,917,687
Market Cap26.3B
Beta1.29
PE Ratio (TTM)66.38
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Street Watches To See If $125,000 Drug Boosts Biogen's Results
    Investor's Business Daily2 days ago

    Street Watches To See If $125,000 Drug Boosts Biogen's Results

    Wall Street will be keyed in Tuesday to Biogen's earnings for a first look at whether payer pushback hindered sales of Spinraza.

  • Alexion (ALXN) Q1 Earnings: Can the Stock Pull a Surprise?
    Zacks3 days ago

    Alexion (ALXN) Q1 Earnings: Can the Stock Pull a Surprise?

    Alexion Pharmaceuticals, Inc. (ALXN) is scheduled to report first quarter 2017 results on Apr 27, before the opening bell.

  • Barrons.com4 days ago

    Gilead Sciences: Who's Frustrated Now?

    Last month, I urged investors to stay away from Gilead Sciences (GILD), arguing that it had, in effect, become a value trap (even if I didn't use those exact words. Barclays analyst Geoff Meacham and team note that "investors seem increasingly more frustrated" with not only Gilead, but with Alexion Pharmaceuticals (ALXN) and Biogen (BIIB) as well.